CXCR4 and hematologic disorder: Examining the expression level of CXCR4 has recently been considered for the development of a PET-based imaging technique and subsequent quantitative evaluation of blood disorders and tumors, including LPDs since this receptor is overexpressed in various blood cells and solid tumors [51,52].